• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Republica Press

Your Business & Political News Source

REPUBLICA PRESS
Your Business & Political News Source

  • Home
  • BUSINESS
  • MONEY
  • POLITICS
  • REAL ESTATE
  • SCIENCE/TECH
  • US
  • WORLD
  • VIDEOS

The U.S. Is Sitting on Tens of Millions of Vaccine Doses the World Needs

by

“If we have a surplus, we’re going to share it with the rest of the world,” Mr. Biden told reporters on Wednesday, speaking generally about the U.S. vaccine supply. “We’re going to start off making sure Americans are taken care of first.”

Johnson & Johnson, which has authorization for its vaccine in the United States but fell behind on its production targets in both the United States and Europe, recently asked the United States to loan 10 million doses to the European Union, but the Biden administration also denied that request, according to American and European officials.

What You Need to Know About the Vaccine Rollout

The European Union has come under fierce criticism for “vaccine nationalism” and protectionism, which intensified last week when Italy blocked a small shipment of doses to Australia, stepping up a tug of war over badly needed shots. Still, the European Union exported 34 million doses of coronavirus vaccines in recent weeks to dozens of countries, even as it faced shortages at home.

As frustrations simmer, some European officials are blaming the United States. The European Council president, Charles Michel, said the United States, along with Britain, “have imposed an outright ban on the export of vaccines or vaccine components produced on their territory.” Asked on Thursday about the American supply of the AstraZeneca vaccine, Jen Psaki, the White House press secretary, told reporters that vaccine manufacturers were free to export their products made in the United States while also fulfilling the terms of their contracts with the government.

But because AstraZeneca’s vaccine was produced with help from the Defense Production Act, Mr. Biden has to approve shipments of doses overseas. Such a move could have huge negative political repercussions as long as Americans are still clamoring for shots.

AstraZeneca is also likely to want liability protection for doses shipped overseas, like it would have in the United States if the vaccine is cleared.

Meantime, regulators in the United States have been waiting for new AstraZeneca data, expected in the next few weeks, from a Phase 3 trial that enrolled 32,000 participants mostly in the United States. AstraZeneca is not likely to report results from an early look at its data, as other vaccine makers have done. It will instead wait for more statistically meaningful results after trial participants have been monitored longer for side effects and more people in the vaccine and placebo groups may have gotten sick, federal officials said. Experts believe the vaccine is unlikely to carry a higher efficacy rate than the shot made by Johnson & Johnson, which uses a similar technology and requires only one dose.

View Source

Filed Under: WORLD Tagged With: AstraZeneca PLC, Biden administration, Biden, Joseph R Jr, Clinical Trials, Coronavirus, Coronavirus (2019-nCoV), COVID-19, Europe, European Union, Food and Drug Administration, Government, Italy, Jen Psaki, Production, Shortages, technology, United States, United States Politics and Government, Vaccination and Immunization

Primary Sidebar

More to See

Western Window Systems launches new streamlined website

PHOENIX--(BUSINESS WIRE)--Western Window Systems, part of PGT Innovations’ (NYSE: PGTI) family of brands, launched a new website this week. The new … [Read More...] about Western Window Systems launches new streamlined website

Homebuilders say U.S. is in a ‘housing recession’ as sentiment turns negative

A worker drills plywood on a single family home under construction in Lehi, Utah, on Friday, Jan. 7, 2022.George Frey | Bloomberg | Getty … [Read More...] about Homebuilders say U.S. is in a ‘housing recession’ as sentiment turns negative

Double Vision: $54M Mirror-Image Mansions Are This Week’s Most Popular Listing

You were seeing double this week: A spectacular $54 million compound featuring two equally luxurious mansions separated by a private lake in Southwest … [Read More...] about Double Vision: $54M Mirror-Image Mansions Are This Week’s Most Popular Listing

Copyright © 2022 · Republica Press · Log in · As an Amazon Associate we earn from qualifying purchases.

Terms and Conditions - Privacy Policy